Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-Refractory Acute Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT02396628
What this trial is testing

Ruxolitinib In GvHD

Who this might be right for
Graft vs Host Disease
Prof. Dr. Nikolas von Bubnoff 22
Testing effectiveness (Phase 2)Study completedNCT00827398
What this trial is testing

Treatment of Steroid Resistant GVHD by Infusion MSC

Who this might be right for
Graft-versus-host-disease
N.M. Wulffraat 50
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Ended earlyNCT01530256
What this trial is testing

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Acute GvHD
CSL Behring 3
Testing effectiveness (Phase 2)UnknownNCT05368181
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Sichuan University 56
Large-scale testing (Phase 3)Looking for participantsNCT06660693
What this trial is testing

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
McMaster University 134
Not applicableApproved For MarketingNCT05722912
What this trial is testing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Post-approval studies (Phase 4)Active Not RecruitingNCT06462469
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Who this might be right for
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)UnknownNCT04971551
What this trial is testing

Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Who this might be right for
Acute Graft-Versus-Host Disease
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06677255
What this trial is testing

A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
Wuhan Optics Valley Vcanbiopharma Co., Ltd. 149
Testing effectiveness (Phase 2)WithdrawnNCT05333029
What this trial is testing

Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD

Who this might be right for
Graft Versus Host Disease
Molly Gallogly
Large-scale testing (Phase 3)Active Not RecruitingNCT04769895
What this trial is testing

MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma 66
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Early research (Phase 1)Looking for participantsNCT06750133
What this trial is testing

Universal CNK-UT Therapy for Refractory aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297069
What this trial is testing

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Who this might be right for
Acute Severe Ulcerative Colitis
Asian Institute of Gastroenterology, India 60
Not applicableAvailableNCT04768907
What this trial is testing

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma
Next Page